Stromal plasma cells expressing immunoglobulin G4 subclass in non–small cell lung cancer by Fujimoto, Masakazu, MD, Yoshizawa, Akihiko, MD, Sumiyoshi, Shinji, MD, Sonobe, Makoto, MD, Kobayashi, Masashi, MD, Koyanagi, Itsuko, Aini, Wulamujiang, PhD, Tsuruyama, Tatsuaki, MD, Date, Hiroshi, MD, Haga, Hironori, MD

Get full text

A Case of a Giant Congenital Melanocytic Nevus Treated by Curettage with the Application of Cultured Epidermal Autografts before 6 Months of Age by Fujito, Hikaru, Yamanaka, Hiroki, Tsuge, Itaru, Katsube, Motoki, Sakamoto, Michiharu, Fujimoto, Masakazu, Morimoto, Naoki

Get full text

Squamous Cell Carcinoma of the Scalp after Artificial Hair Implantation by Nakayama, Satoru, Tsuge, Itaru, Katsuragawa, Hiroyuki, Fujimoto, Masakazu, Fujimori, Hideyuki, Katsube, Motoki, Sakamoto, Michiharu, Morimoto, Naoki

Get full text

Lung adenocarcinoma with MUC4 expression is associated with smoking status, HER2 protein expression, and poor prognosis: Clinicopathological analysis of 338 cases by Rokutan-Kurata, Mariyo, MD, Yoshizawa, Akihiko, MD, PhD, Sumiyoshi, Shinji, MD, PhD, Sonobe, Makoto, MD, PhD, Menju, Toshi, MD, PhD, Momose, Masanobu, PhD, Koyama, Mizuki, Shigeto, Shohei, Fujimoto, Masakazu, MD, PhD, Zhang, Meng, MD, Morita, Satoshi, PhD, Date, Hiroshi, MD, PhD, Haga, Hironori, MD, PhD

Get full text

Serial Changes in von Willebrand Factor-Cleaving Protease (ADAMTS13) and Prognosis After Acute Myocardial Infarction by Matsukawa, Masakazu, MD, Kaikita, Koichi, MD, Soejima, Kenji, PhD, Fuchigami, Shunichiro, MD, Nakamura, Yoshinori, MD, Honda, Tsuyoshi, MD, Tsujita, Kenichi, MD, Nagayoshi, Yasuhiro, MD, Kojima, Sunao, MD, Shimomura, Hideki, MD, Sugiyama, Seigo, MD, Fujimoto, Kazuteru, MD, Yoshimura, Michihiro, MD, Nakagaki, Tomohiro, PhD, Ogawa, Hisao, MD

Get full text

Sleep Apnea Syndrome in Patients with Atrial Fibrillation —2 Cases Whose Atrial Fibrillation Was Controlled by Treatment for Sleep Apnea Syndrome by Fujimoto, Manabu, Masakazu, Yamamoto

Request full text

Efficacy and tolerability of varenicline, an α4 β2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week... by Nakamura, Masakazu, MD, Oshima, Akira, MD, Fujimoto, Yoko, MD, PhD, Maruyama, Nami, MSc, Ishibashi, Taro, MSc, Reeves, Karen R., MD

Get full text